Neuromuscular blocking agents and reversal agents

被引：0

作者：

Ahmad, Shahzaib ^{[1
]}

Handslip, Rhodri ^{[1
]}

机构：

[1] St Georges Univ Hosp NHS Trust, Intens Care Med, London, England

来源：

ANAESTHESIA AND INTENSIVE CARE MEDICINE | 2024年 / 25卷 / 09期

关键词：

Acetylcholine; aminosteroid; benzylisoquinolinium; neostigmine; neuromuscular blocking drugs; neuromuscular junction; succinylcholine; sugammadex;

D O I：

10.1016/j.mpaic.2024.07.001

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

The neuromuscular junction is a complex structure consisting of the muscle cell, the nerve terminal of a motor neuron and the synaptic cleft. It is the site of action for neuromuscular blocking drugs, which are a cornerstone of anaesthetic practice. These drugs can be divided into depolarizing and non-depolarizing drugs; the latter can be further subdivided into benzylisoquinolinium and aminosteroid compounds. Reversal agents are also discussed. The pharmacology of neuromuscular blocking drugs and reversal agents is discussed including mechanism of action, metabolism, factors influencing choice of drug as well as adverse effect profile.

引用

页码：595 / 599

页数：5

共 50 条

[21] News on anaphylaxis related to neuromuscular blocking agents [J].

Malinovsky, J. M. ;

Tacquard, C. ;

Chiriac, A. M. ;

Perotin, J. M. ;

Demoly, P. ;

Mertes, P. M. .

REVUE FRANCAISE D ALLERGOLOGIE, 2017, 57 (08) :547-550

[22] Neuromuscular Blocking Agents and Monitoring in the Equine Patient [J].

Martin-Flores, Manuel .

VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE, 2013, 29 (01) :131-+

[23] Investigation of intraoperativedosing patterns of neuromuscular blocking agents [J].

Palsen, Sarah ;

Wu, Albert ;

Beutler, Sascha S. ;

Gimlich, Robert ;

Yang, H. Keri ;

Urman, Richard D. .

JOURNAL OF CLINICAL MONITORING AND COMPUTING, 2019, 33 (03) :455-462

[24] Newer Neuromuscular Blocking AgentsHow do They Compare with Established Agents? [J].

Harald J. Sparr ;

Ton M. Beaufort ;

Thomas Fuchs-Buder .

Drugs, 2001, 61 :919-942

[25] Appropriate Use of Neuromuscular Blocking Agents and Reversal Drugs to Enhance Recovery Following Cardiac Surgery [J].

Rebecca M. Gerlach ;

Mark A. Chaney .

Current Anesthesiology Reports, 2020, 10 :267-272

[26] Effects of Neostigmine Reversal of Nondepolarizing Neuromuscular Blocking Agents on Postoperative Respiratory Outcomes A Prospective Study [J].

Sasaki, Nobuo ;

Meyer, Matthew J. ;

Malviya, Sanjana A. ;

Stanislaus, Anne B. ;

MacDonald, Teresa ;

Doran, Mary E. ;

Igumenshcheva, Arina ;

Hoang, Alan H. ;

Eikermann, Matthias .

ANESTHESIOLOGY, 2014, 121 (05) :959-968

[27] Neostigmine-based reversal of intermediate acting neuromuscular blocking agents to prevent postoperative residual paralysis [J].

Tajaate, Najat ;

Schreiber, Jan-Uwe ;

Fuchs-Buder, Thomas ;

Jelting, Yvonne ;

Kranke, Peter .

EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2018, 35 (03) :184-192

[28] Pharmacoeconomic issues related to selection of neuromuscular blocking agents [J].

White, PF .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (11) :S18-S21

[29] Emergency department use of neuromuscular blocking agents in children [J].

Doobinin, KA ;

Nakagawa, TA .

PEDIATRIC EMERGENCY CARE, 2000, 16 (06) :441-447

[30] Neuromuscular blockers and reversal agents and their impact on anesthesia practice [J].

Zafirova, Zdravka ;

Dalton, Allison .

BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2018, 32 (02) :203-211

← 1 2 3 4 5 →